1. Detection of exogenous gene doping of IGF-I by a real-time quantitative PCR assay
- Author
-
Shi-Jiao Ma, Jing-Feng Xu, Chun Zhang, Ting-Ting Zhang, Xiao-Mei Liu, Jin-ju Zhang, Qing-Lin Meng, Wen-Jun Lan, and Yong-Wei Shen
- Subjects
0301 basic medicine ,Biomedical Engineering ,Bioengineering ,Biology ,01 natural sciences ,Applied Microbiology and Biotechnology ,law.invention ,03 medical and health sciences ,Exon ,Plasmid ,law ,Gene doping ,Drug Discovery ,TaqMan ,Gene ,Process Chemistry and Technology ,010401 analytical chemistry ,General Medicine ,DNA extraction ,Molecular biology ,0104 chemical sciences ,030104 developmental biology ,Real-time polymerase chain reaction ,Recombinant DNA ,Molecular Medicine ,Biotechnology - Abstract
Gene doping can be easily concealed since its product is similar to endogenous protein, making its effective detection very challenging. In this study, we selected insulin-like growth factor I (IGF-I) exogenous gene for gene doping detection. First, the synthetic IGF-I gene was subcloned to recombinant adeno-associated virus (rAAV) plasmid to produce recombinant rAAV2/IGF-I-GFP vectors. Second, in an animal model, rAAV2/IGF-I-GFP vectors were injected into the thigh muscle tissue of mice, and then muscle and blood specimens were sampled at different time points for total DNA isolation. Finally, real-time quantitative PCR was employed to detect the exogenous gene doping of IGF-I. In view of the characteristics of endogenous IGF-I gene sequences, a TaqMan probe was designed at the junction of exons 2 and 3 of IGF-I gene to distinguish it from the exogenous IGF-I gene. In addition, an internal reference control plasmid and its probe were used in PCR to rule out false-positive results through comparison of their threshold cycle (Ct) values. Thus, an accurate exogenous IGF-I gene detection approach was developed in this study.
- Published
- 2017
- Full Text
- View/download PDF